Lebrikizumab, sold under the brand name Ebglyss is a humanized monoclonal antibody used for the treatment of atopic dermatitis (atopic eczema). The most...

hypereosinophilic leukemia Monoclonal antibodies such as dupilumab and lebrikizumab target IL-13 and its receptor, which reduces eosinophilic inflammation...

that use anti-IL-13 monoclonal antibodies include tralokinumab, and lebrikizumab. These treatments have shown improvements in asthma patients, yet there...

Cintredekin besudotox Interleukin 4 Interleukin 13 Antibodies: Anrukinzumab Lebrikizumab Tralokinumab IL-15 Agonists: ALT-803 Interleukin 15 IL-17 Agonists: Interleukin...

announced its acquisition of Dermira for $1.1 billion, gaining control of lebrikizumab,glycopyrronium cloth used in the treatment of hyperhidrosis, and other...

are approved to treat moderate-to-severe eczema in the US and the EU. Lebrikizumab is also approved in the EU for treating moderate-to-severe AD but in...

blockers: Benralizumab Mepolizumab Reslizumab IL-13-specific blockers: Lebrikizumab Tralokinumab Dual IL-4 and IL-13 blockers: Dupilumab IgE-blockers: Ligelizumab...

Cintredekin besudotox Interleukin 4 Interleukin 13 Antibodies: Anrukinzumab Lebrikizumab Tralokinumab IL-15 Agonists: ALT-803 Interleukin 15 IL-17 Agonists: Interleukin...

Cintredekin besudotox Interleukin 4 Interleukin 13 Antibodies: Anrukinzumab Lebrikizumab Tralokinumab IL-15 Agonists: ALT-803 Interleukin 15 IL-17 Agonists: Interleukin...

for IPF, including the monoclonal antibodies simtuzumab, tralokinumab, lebrikizumab and FG-3019, a lysophosphatidic acid receptor antagonist (BMS-986020)...